HomeGeneticsConditionCLCN2-related leukoencephalopathy
Back to Condition
CLCN2-related leukoencephalopathy
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

CLCN2-related leukoencephalopathy

CLCN2-related leukoencephalopathy is a brain disorder characterized by white matter abnormalities that can lead to coordination issues, headaches, and vision problems.

Overview

CLCN2-related leukoencephalopathy affects the brain, with symptoms appearing anytime from childhood to adulthood. The condition is generally stable and does not worsen significantly over time. It is characterized by leukoencephalopathy, an abnormality of the brain's white matter where the myelin—the fatty substance insulating nerve fibers—becomes fluid-filled (edematous), impairing nerve impulse transmission.

Symptoms

  • Ataxia (difficulty with coordination and balance)
  • Frequent headaches
  • Learning disabilities (typically in childhood-onset cases)
  • Vision problems, including retinopathy or atrophy of the optic nerves (typically in adult-onset cases)
  • Mild muscle stiffness (spasticity)
  • Infertility in affected males
  • Potential, though unconfirmed, symptoms include dizziness, tinnitus, hearing loss, and psychiatric disorders

Causes

The condition is caused by mutations in the CLCN2 gene, which provides instructions for making a chloride channel protein called ClC-2. These channels transport chloride ions across cell membranes and are vital for maintaining the volume of neurons and the balance of ions within cells.

Mutations in the CLCN2 gene lead to a reduction or complete loss of ClC-2 channel function. This causes brain cells and the myelin surrounding neurons to accumulate excess water, preventing effective nerve impulse transmission and resulting in the neurological symptoms observed in this disorder.

Inheritance

This condition is inherited in an autosomal recessive pattern. Both copies of the gene in each cell must have mutations. Parents of an affected individual typically carry one copy of the mutated gene but do not exhibit symptoms.

Frequently Asked Questions

Management is symptomatic and supportive. For ataxia, physical therapy is essential to improve balance and reduce fall risk, and patients may need to use assistive devices like canes or walkers. For visual problems, regular ophthalmologic evaluations are necessary to monitor optic nerve health and manage retinopathy. Occupational therapy can help adapt the home and workplace environment to accommodate reduced coordination and visual acuity, ensuring safety and independence.
Diagnosis relies on a combination of brain MRI and genetic testing. An MRI will show characteristic white matter changes, specifically edematous or fluid-filled myelin, often with a specific pattern of involvement. Definitive confirmation requires genetic sequencing of the CLCN2 gene to identify biallelic pathogenic variants. Clinicians must rule out other causes of leukoencephalopathy, such as mitochondrial disorders or metabolic conditions, through blood and urine metabolic panels if genetic testing is inconclusive.
The age of onset influences which neural pathways are primarily affected during the period of myelin maturation. Childhood-onset cases typically present with ataxia, learning disabilities, and spasticity because the developing motor and cognitive circuits are disrupted early. Adult-onset cases often manifest with visual disturbances, such as retinopathy or optic nerve atrophy, and frequent headaches, suggesting that the white matter changes impact visual processing centers or cause increased intracranial pressure symptoms later in life.
The condition is generally considered stable and non-progressive, meaning it does not typically worsen significantly over time. Unlike many other leukodystrophies, patients do not usually experience a rapid decline in function. However, the neurological deficits present at diagnosis, such as balance issues or visual impairment, are permanent. Long-term management focuses on maintaining quality of life and monitoring for potential complications like infertility in males.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab

Sök
Om ossVillkor och policyVanliga frågorKontakta oss